findmyKOL
Clinical trialNCT07419841RecruitingPhase 1Interventional

A Phase 1 Study of the Safety and Tolerability of CTX-10726

SponsorCompass TherapeuticsEnrollment70Endometrial CancerGastroesophageal Cancer (GC)Hepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase 1, open-label, first-in-human study of CTX-10726 monotherapy in patients with metastatic or locally advanced malignancies. The study will be conducted in 2 Cohorts: Cohort 1 Dose Escalation and Cohort 2 Dose Expansion.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Nebraska Cancer Specialists

    Omaha, Nebraska, United States

    Ralph Hauke, MD
    Recruiting
  • Start New York

    Lake Success, New York, United States

    Geraldine O'Sullivan Coyne, MD, PhD
    Recruiting
  • Upmc Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

    Diwakar Davar, MD
    Recruiting
  • Prisma Health Cancer Institute

    Greenville, South Carolina, United States

    Jeff Edenfield, MD
    Recruiting
  • Scri Oncology Partners

    Nashville, Tennessee, United States

    Meredith Pelster, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CTX-10726
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 May 2026
Primary completion
1 Apr 2028
Completion
1 Nov 2028
Last update posted
31 Jul 2026
Registered enrollment
70
Registry id
NCT07419841
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.